Recon: Lilly to seek accelerated approval for its Alzheimer’s drug; FDA to add warning about rare heart inflammation to Pfizer, Moderna vaccines
ReconMichael Mezher
BiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticalsReconMichael MezherBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticals